Matšoao a lefu la renal cell carcinoma pathology

Renal Cell Carcinoma Pathology Outlines: Tataiso e FeletsengRenal cell carcinoma (RCC) ke lefu le rarahaneng, 'me ho utloisisa lefu la lona ho bohlokoa bakeng sa tlhahlobo e nepahetseng le kalafo. Tataiso ena e fana ka kakaretso ea kakaretso ea Matšoao a lefu la renal cell carcinoma pathology, e koahelang likarolo tsa bohlokoa tsa histological, subtypes, le mekhoa ea ho hlahloba.

Likarolo tsa Histological tsa Renal Cell Carcinoma

Hlakola Cell Renal Cell Carcinoma

Mofuta o tloaelehileng ka ho fetisisa oa RCC, clear cell carcinoma, o khetholloa ke cytoplasm ea eona e hlakileng. Sena se bakoa ke ho bokellana ha lipids le glycogen ka har'a lisele. Ka microscopically, hangata u tla bona lisele tse hlophisitsoeng ka lihlaha kapa papillae, tse nang le li-nuclei tse hlahelletseng. Ho ba teng ha eosinophilic granular cytoplasm le hona ho tloaelehile. Boitsebiso bo nepahetseng bo itšetlehile ka tlhahlobo e feletseng ea histological, hangata e tlatsitsoeng ke immunohistochemistry ho netefatsa hore na o fumanoa hokae. Lipatlisiso tse ling li ka kenyelletsa tlhahlobo ea liphatsa tsa lefutso ho fumana liphetoho tse ka bang teng, ho tsebisa mekhoa ea kalafo ea motho ka mong.

Papillary Renal Cell Carcinoma

Papillary RCC ke karolo e 'ngoe ea bohlokoa e khetholloang ka mokhoa oa eona oa kholo ea papillary. Lisele li atisa ho hlophisoa ka li-papillae tse ikhethang, hangata li bontša pseudostratification. Nuclear atypia e fapana ho latela kereiti, 'me limaraka tse holimo li bonts'a liphoso tse kholo. Immunohistochemical staining e ka thusa ho e khetholla ho mefuta e meng ea RCC le urothelial carcinoma. Bakeng sa kutloisiso e tebileng, ho hlahloba litemana tse khethehileng tsa pathology le lisebelisoa tsa marang-rang tse tsoang mekhatlong e hlomphehang joaloka National Cancer Institute (NCI) ho ka ba molemo.

Chromophobe Renal Cell Carcinoma

Chromophobe RCC, joalo ka ha lebitso le fana ka maikutlo, e tšoauoa ka lisele tse nang le cytoplasm e mosehla, e hlakileng le meeli e ikhethang ea lisele. Hangata li-nuclei li pota-potile 'me li le bohareng. Subtype ena hangata e bonts'a sebopeho sa perinuclear halo. This distinct morphology is typically enough for diagnosis, although immunohistochemistry can be helpful in confirming the diagnosis and excluding other tumors. Mekhoa e tsoetseng pele ea ho nka litšoantšo e kang computed tomography (CT) scans le eona e sebelisoa ho netefatsa hore na ho ameha ha hlahala hakae.

Mefuta e meng e ka tlase ea Renal Cell Carcinoma

Beyond the three major subtypes, several rarer variants exist, including collecting duct carcinoma, medullary RCC, and mucinous tubular and spindle cell carcinoma. Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa (https://www.baofahospital.com/) se fana ka bokhoni bo tsoetseng pele ba tlhahlobo le boitseanape ba ho sebetsana le mefuta ena e sa tloaelehang ea RCC. Sehlopha sa bona se inehetseng sa lingaka se sebelisa mahlale a morao-rao ho netefatsa tlhahlobo e nepahetseng le e nakong.

Mekhoa ea ho hlahloba le Immunohistochemistry

Ho hlahloba Renal cell carcinoma hangata e kenyelletsa mekhoa ea ho etsa litšoantšo (joaloka CT scans le MRI) le tlhahlobo ea histological ea li-tissue biopsies. Immunohistochemistry e bapala karolo ea bohlokoa ho aroleng li-subtypes tse fapaneng le ho bolela esale pele. Matšoao a khethehileng, a kang CD10, vimentin, le AMACR, a atisa ho sebelisoa ho khetholla pakeng tsa mefuta e sa tšoaneng ea RCC. The Shandong Baofa Cancer Research Institute employs a comprehensive panel of immunohistochemical markers in their diagnostic workup to deliver precise diagnoses.

Lintlha tsa Prognostic le Staging

Boloetse ba bakuli ba nang le RCC bo fapana haholo ho latela lintlha tse fapaneng, ho kenyeletsoa sethala sa tumor, sehlopha le subtype. Sistimi ea TNM e atisa ho sebelisoa ho khetholla boholo ba ho ata ha mofetše. Ho utloisisa lintlha tsa prognostic ke habohlokoa bakeng sa ho tataisa liqeto tsa phekolo le ho laola litebello tsa mokuli. The information provided in this outline is intended for educational purposes and should not substitute advice from a qualified medical professional. Kamehla batla tataiso ea lingaka.

Lethathamo: Papiso ea RCC Subtypes

Mofuta o monyane	Likarolo tsa Histological	Liphello tsa Prognostic
Hlakola Seleng	Cytoplasm e hlakileng, lihlaha/papillae	E feto-fetohang, hangata e itšetlehile ka sethala
Papillary	Mokhoa oa ho hōla ha Papillary, pseudostratification	Ka kakaretso prognoza e ntle ha e bapisoa le lisele tse hlakileng
Chromophobe	Pale cytoplasm, meeli e ikhethang ea lisele	Ka kakaretso prognosis e ntle

Kakaretso ena e fana ka motheo oa kutloisiso Matšoao a lefu la renal cell carcinoma pathology. Bakeng sa ho ikakhela ka setotsoana likarolong tse itseng, ho khothaletsoa ho sheba lingoliloeng tsa bongaka tse amehang le mehloli e tsebahalang ea inthanete. Hopola ho buisana le setsebi sa tlhokomelo ea bophelo kamehla bakeng sa likeletso tsa hau le moralo oa kalafo.

Boitlhotlhollo: Litaba tsena ke tsa sepheo sa thuto feela 'me ha lia lokela ho nkoa e le keletso ea bongaka. Kamehla buisana le setsebi sa bophelo bo botle se tšoanelehang bakeng sa tlhahlobo le kalafo.